These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1377542)

  • 1. A monoclonal antibody (E-9) binds preferentially to the vasculatures of human tumors, embryonic and regenerating tissues.
    Wang JM; Hunter RD; Kumar S
    EXS; 1992; 61():266-71. PubMed ID: 1377542
    [No Abstract]   [Full Text] [Related]  

  • 2. A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues.
    Wang JM; Kumar S; Pye D; van Agthoven AJ; Krupinski J; Hunter RD
    Int J Cancer; 1993 May; 54(3):363-70. PubMed ID: 8509210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of mouse monoclonal antibodies against a human vascular endothelial cell-specific antigen.
    Winzer-Serhan UH; Schäfer H; Friedl P
    Eur J Cell Biol; 1993 Feb; 60(1):42-7. PubMed ID: 8462599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma.
    Schlingemann RO; Rietveld FJ; de Waal RM; Bradley NJ; Skene AI; Davies AJ; Greaves MF; Denekamp J; Ruiter DJ
    Lab Invest; 1990 Jun; 62(6):690-6. PubMed ID: 1694254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis.
    Castellani P; Viale G; Dorcaratto A; Nicolo G; Kaczmarek J; Querze G; Zardi L
    Int J Cancer; 1994 Dec; 59(5):612-8. PubMed ID: 7525495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistological studies with monoclonal antibodies.
    Hancock WW; Atkins RC
    Methods Enzymol; 1986; 121():828-48. PubMed ID: 3088388
    [No Abstract]   [Full Text] [Related]  

  • 7. E-selectin targeting to visualize tumors in vivo.
    Hirai M; Hiramatsu Y; Iwashita S; Otani T; Chen L; Li YG; Okada M; Oie K; Igarashi K; Wakita H; Seno M
    Contrast Media Mol Imaging; 2010; 5(2):70-7. PubMed ID: 20235150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel anti-von Willebrand factor monoclonal antibodies.
    Spadafora-Ferreira M; Lopes AA; Coelho V; Guilherme L; Kalil J
    Thromb Res; 2000 Jan; 97(2):3-13. PubMed ID: 10688330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the vasculature of solid tumours.
    Murray JC; Hewett PW; Martin SG
    QJM; 1996 Mar; 89(3):165-7. PubMed ID: 8731559
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibodies to damaged and regenerating vascular endothelium.
    Pringle S; de Bono DP
    J Clin Lab Immunol; 1988 Aug; 26(4):159-62. PubMed ID: 2462052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of anti-hECSM2 mouse monoclonal antibodies and their application in the analysis of hECSM2 expression.
    Chen L; Ma C; He J; He Y; Wang J; Gou L; Yang J
    Monoclon Antib Immunodiagn Immunother; 2013 Aug; 32(4):301-8. PubMed ID: 23909426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of antibody conjugated, phosphatidylserine-containing liposomes to vascular cell adhesion molecule 1 for controlled thrombogenesis.
    Chiu GN; Bally MB; Mayer LD
    Biochim Biophys Acta; 2003 Jun; 1613(1-2):115-21. PubMed ID: 12832092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of angiogenic potential--the use of AIDS-KS cell supernatants as an in vitro model.
    Adatia R; Poggi L; Thompson EW; Gallo RC; Fassina GF; Albini A
    EXS; 1992; 61():321-6. PubMed ID: 1377551
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody-directed targeting of the vasculature of solid tumors.
    Thorpe PE; Burrows FJ
    Breast Cancer Res Treat; 1995; 36(2):237-51. PubMed ID: 8534871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential expression of a 130,000-Da cell surface protein by vascular wall cells in vitro and in vivo.
    Risau W; Sweet E; D'Amore PA
    Microvasc Res; 1988 May; 35(3):265-77. PubMed ID: 3292878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds.
    Schlingemann RO; Rietveld FJ; de Waal RM; Ferrone S; Ruiter DJ
    Am J Pathol; 1990 Jun; 136(6):1393-405. PubMed ID: 1694058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.
    Seon BK; Matsuno F; Haruta Y; Kondo M; Barcos M
    Clin Cancer Res; 1997 Jul; 3(7):1031-44. PubMed ID: 9815781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody against α-actinin 4 from human umbilical vein endothelial cells inhibits endothelium-dependent vasorelaxation.
    Won KJ; Lee KP; Kim DK; Jung SH; Lee CK; Lee DH; Yu SY; Park SH; Lee HM; Kim B
    J Vasc Res; 2013; 50(3):210-20. PubMed ID: 23711888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle regulated promoters for the targeting of tumor endothelium.
    Nettelbeck DM; Zwicker J; Lucibello FC; Gross C; Liu N; Brüsselbach S; Müller R
    Adv Exp Med Biol; 1998; 451():437-40. PubMed ID: 10026908
    [No Abstract]   [Full Text] [Related]  

  • 20. Hanging-drop multicellular spheroids as a model of tumour angiogenesis.
    Timmins NE; Dietmair S; Nielsen LK
    Angiogenesis; 2004; 7(2):97-103. PubMed ID: 15516830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.